Exothera Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 159

Employees

  • Latest Deal Type
  • Liquidation

Exothera General Information

Description

Provider of contract manufacturing and development services intended to design and deliver affordable viral vector-based vaccines and cell and gene therapies. The company capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide custom-made process optimization and GMP clinical and commercial production of viral vectors, enabling customers with services such as process analysis, design, and development for cost-effective and agile viral vector manufacturing.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Rue de la Maîtrise 11
  • 1400 Nivelles
  • Belgium
+32 071
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Rue de la Maîtrise 11
  • 1400 Nivelles
  • Belgium
+32 071

Exothera Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Exothera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Bankruptcy: Liquidation 26-Aug-2025 Completed Bankruptcy: Liquidation
4. Later Stage VC 23-Jan-2025 Completed Generating Revenue
3. Early Stage VC 20-Feb-2024 Completed Generating Revenue
2. Early Stage VC 01-Aug-2022 $23.4M $23.4M Completed Generating Revenue
1. Debt - General 01-Jun-2021 Completed Generating Revenue
To view Exothera’s complete valuation and funding history, request access »

Exothera Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view Exothera’s complete cap table history, request access »

Exothera Patents

Exothera Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12203126-B2 System and method for clarifying a cell culture harvest solution Active 11-May-2018
US-20210189454-A1 System and method for clarifying a cell culture harvest solution Active 11-May-2018
ES-2957624-T3 Use of flexible or compressible coatings in a system and method for clarifying a cell culture harvest solution Active 11-May-2018
EP-3790983-A2 Use of flexible or compressible liners in a system and method for clarifying a cell culture harvest solution Active 11-May-2018
EP-3790983-B1 Use of flexible or compressible liners in a system and method for clarifying a cell culture harvest solution Active 11-May-2018 C12Q1/24
To view Exothera’s complete patent history, request access »

Exothera Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Exothera FAQs

  • When was Exothera founded?

    Exothera was founded in 2020.

  • Where is Exothera headquartered?

    Exothera is headquartered in Nivelles, Belgium.

  • What is the size of Exothera?

    Exothera has 159 total employees.

  • What industry is Exothera in?

    Exothera’s primary industry is Drug Discovery.

  • Is Exothera a private or public company?

    Exothera is a Private company.

  • What is Exothera’s current revenue?

    The current revenue for Exothera is .

  • How much funding has Exothera raised over time?

    Exothera has raised $69.6M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process